What are the best treatments for Hypoplastic Left Heart Syndrome?

Hypoplastic Left Heart Syndrome (HLHS) is a complex congenital heart defect that requires a staged surgical approach, typically beginning shortly after birth, to reconstruct the heart’s anatomy and redirect blood flow. Treatment is highly personalized and centered on a series of three palliative surgeries, often supplemented by lifelong cardiac monitoring and, in some cases, heart transplantation.

What are the primary surgical treatments for Hypoplastic Left Heart Syndrome?

Because the left side of the heart is underdeveloped in Hypoplastic Left Heart Syndrome, a series of three operations is standard to create a functional circulation system. The first procedure, the Norwood operation, is usually performed within the first two weeks of life. This is followed by the Glenn procedure (typically at 4–6 months) and the Fontan procedure (typically between 18 months and 4 years). Some infants with Hypoplastic Left Heart Syndrome may be candidates for a heart transplant if their anatomy is not suitable for the staged reconstruction.

What medications and supportive therapies are used?

Medical management for Hypoplastic Left Heart Syndrome is essential to support cardiac function and prevent complications. Common medications and therapies include:

• Prostaglandins (Alprostadil): Administered intravenously to keep the ductus arteriosus open until the first surgery.


• Diuretics (Furosemide): Used to manage fluid retention and reduce the workload on the heart.


• ACE Inhibitors (Enalapril/Lisinopril): Often prescribed to help lower blood pressure and improve heart efficiency.


• Anticoagulants (Aspirin/Warfarin): Used to prevent blood clots, particularly after the Fontan procedure.


• Developmental Therapies: Physical and occupational therapy are vital to address neurodevelopmental delays often associated with Hypoplastic Left Heart Syndrome.

Which specialists are required for the care team?

Managing Hypoplastic Left Heart Syndrome requires a multidisciplinary team approach to ensure comprehensive care. Essential specialists include:

• Pediatric cardiologists and cardiothoracic surgeons


• Electrophysiologists (to manage heart rhythm issues)


• Heart failure and transplant specialists


• Developmental pediatricians and physical therapists


• Social workers and psychologists to support the emotional well-being of families

How does treatment effectiveness vary?

The long-term outcomes for Hypoplastic Left Heart Syndrome vary significantly based on the infant's specific anatomy, the presence of other genetic conditions, and the success of each surgical stage. While these procedures are life-saving, Hypoplastic Left Heart Syndrome remains a lifelong condition requiring ongoing specialized cardiac care and monitoring for complications like arrhythmias or heart failure.

Next steps

• Consult with a pediatric cardiothoracic surgeon at a high-volume congenital heart center.


• Connect with the 28 members of our community at DiseaseMaps.org who are living with or caring for someone with this condition.


• Discuss neurodevelopmental screening with your care team to address potential learning or motor challenges early.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice; always consult your personal medical team regarding treatment decisions and dosages.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: Hypoplastic Left Heart Syndrome


• American Heart Association (AHA) - Congenital Heart Defects


• Children's Heart Foundation